Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:5
|
作者
Papadopoulos, Efthymios [1 ,2 ]
Alibhai, Shabbir M. H. [2 ,3 ,4 ]
Tomlinson, George A. [3 ,4 ,6 ]
Matthew, Andrew G. [3 ,4 ]
Nesbitt, Michael [5 ]
Finelli, Antonio [3 ,5 ]
Trachtenberg, John [3 ,5 ]
Santa Mina, Daniel [1 ,2 ,3 ]
机构
[1] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment; EXERCISE; LIFE;
D O I
10.1007/s10552-019-01211-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Epidemiologic data suggest that high levels of physical activity (PA) may reduce the risk of disease progression in men with prostate cancer (PCa), but it is unknown whether PA can delay the requirement for definitive treatment for those on active surveillance (AS). We investigated the influence of PA post-diagnosis on AS discontinuation in men with low-risk disease. Methods The effect of PA on the time to AS discontinuation was assessed in 421 patients, of whom 107 underwent additional PCa treatment over a median of 2.5 years. Results Using Cox regression models, we found that PA was not significantly associated with time to curative treatment initiation. Prostate-specific antigen (PSA) most proximal to AS initiation (HR, 1.11; 95% CI 1.03 to 1.21) and the number of positive cores (HR, 1.34; 95% CI 1.12 to 1.61) at diagnosis were associated with a significantly increased risk of discontinuing AS. Conclusion Our findings suggest that PA during AS for PCa does not significantly influence time to curative treatment.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 50 条
  • [21] Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol
    Sosnowski, Roman
    Kamecki, Hubert
    Daneshmand, Siamak
    Rudzinski, Jan K.
    Bjurlin, Marc A.
    Giganti, Francesco
    Roobol, Monique J.
    Klotz, Laurence
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 123 - 126
  • [22] Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features
    Suardi, Nazareno
    Capitanio, Umberto
    Chun, Felix K. H.
    Graefen, Markus
    Perrotte, Paul
    Schlomm, Thorsten
    Haese, Alexander
    Huland, Hartwig
    Erbersdobler, Andreas
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    CANCER, 2008, 113 (08) : 2068 - 2072
  • [23] African American Men With Low-Risk Prostate Cancer Are Candidates for Active Surveillance: The Will-Rogers Effect?
    Qi, Robert
    Moul, Judd
    AMERICAN JOURNAL OF MENS HEALTH, 2017, 11 (06) : 1765 - 1771
  • [24] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [25] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [26] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [27] Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer
    Womble, Paul R.
    Montie, James E.
    Ye, Zaojun
    Linsell, Susan M.
    Lane, Brian R.
    Miller, David C.
    EUROPEAN UROLOGY, 2015, 67 (01) : 44 - 50
  • [28] Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
    Sathianathen, Niranjan J.
    Konety, Badrinath R.
    Alarid-Escudero, Fernando
    Lawrentschuk, Nathan
    Bolton, Damien M.
    Kuntz, Karen M.
    EUROPEAN UROLOGY, 2019, 75 (06) : 910 - 917
  • [29] Selecting Active Surveillance: Decision-Making Factors for Men with a Low-Risk Prostate Cancer
    Hoffman, Richard M.
    Lobo, Tania
    Van Den Eeden, Stephen K.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst D.
    Aaronson, David
    Penson, David F.
    Taylor, Kathryn
    MEDICAL DECISION MAKING, 2019, 39 (08) : 962 - 974
  • [30] Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi, Arun
    Ruterbusch, Julie
    Reamer, Elyse
    Eggly, Susan
    Xu, Jinping
    FAMILY PRACTICE, 2017, 34 (01) : 90 - 97